SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Zcash is a privacy-focused cryptocurrency that uses trustless zero-knowledge proofs to enable fully encrypted transactions while maintaining blockchain transparency and security. It was the first cryptocurrency to implement zero-knowledge encryption for private peer-to-peer payments, addressing the fundamental privacy gap in traditional cryptocurrencies that expose transaction details publicly.   With a fixed supply of 21 million ZEC and a halving schedule similar to Bitcoin, Zcash allows users to prove transactions are valid without revealing sensitive information like wallet balances, transaction amounts, or participant identities, making it suitable for everyday payments, long-term savings, and cross-border money transfers where financial confidentiality matters.  The protocol operates on its own blockchain currently using Proof-of-Work consensus, though it's evolving toward Proof-of-Stake through the planned "Crosslink" upgrade to enhance security, scalability, and energy efficiency. Zcash employs trustless zero-knowledge proofs (Halo) within its Orchard shielded pool to verify transactions without revealing sender, receiver, or amount information.   Users can choose between transparent public transactions and shielded private transactions through Unified Addresses, which work with both types. The network is faster and cheaper than Bitcoin, with new blocks mined every 75 seconds and transaction fees typically just a fraction of a cent. Privacy adoption has surged in 2025, with over 30% of total ZEC supply now held in fully shielded pools.  Zcash was created by a group of scientists in 2013 who initially proposed Zerocoin as a privacy extension to Bitcoin before building a standalone protocol. The ecosystem operates with a self-funded development model where block rewards support independent teams through the Zcash Community Grants Committee and a new Coinholder-Controlled Fund.

Zcash

Zcash is trending amid community discussion around its potential as 'the new Bitcoin' and increased institutional interest, particularly following investments from figures like the Winklevoss twins. Conversations highlight ZEC's privacy features and limited supply, with some suggesting a significant shift from Bitcoin to Zcash. Bullish sentiment is tempered by concerns about volatility and potential corrections.

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is trending as the crypto community discusses its potential breakout, referencing patterns observed in Zcash's previous run. Bullish sentiment is fueled by the anticipation of a government reopening and the LTCN ETF, with some eyeing price targets in the hundreds. Technical analysis chatter includes inverted head and shoulders patterns and golden cross formations, suggesting a possible surge if key resistance levels are breached.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is trending amidst heightened speculation and community chatter surrounding the release of Epstein files and their potential implications for the company and its figureheads. The community is actively dissecting alleged connections and potential fallouts, while some voice concerns about the company's financial performance. Political narratives and partisan bickering continue to fuel the conversation around the stock.

XPeng, Inc. engages in the design, development, manufacture, and marketing of smart electric vehicles. Its products are environmentally friendly vehicles, namely an SUV (the G3) and a four-door sports sedan (the P7). It also provides a range of services to the clients, including supercharging service, maintenance service, ride-hailing service and vehicle leasing service. The company was founded by Xiao Peng He, Heng Xia, and Tao He in 2015 and is headquartered in Guangzhou, China.

XPeng Inc - ADR

XPEV is trending as investors discuss upcoming earnings and the company's potential for profitability, with some anticipating a positive report. Community members are also highlighting XPEV's expansion into robotics and AI, seeing it as more than just an EV company and comparing its progress to competitors. Bullish sentiment seems to be growing, although some concerns about cash flow and potential dilution remain.

The community has officially TAKEN OVER $HIPPO - after the dev threw in the towel! The cutest $HIPPO on SUI is now powered by a full CTO. No cats, no dogs. Only $HIPPO, driven by the people, for the people! $HIPPO is ready to break out stronger than ever!  Su Deng is the cutest $HIPPO on SUI, bringing $HIPPO to the world of memes.  $HIPPO - No cats, no dogs Only hippo!  We are donating a % of our profits to wildlife needs across the world. Starting with support for Khao Kheow Open Zoo, the zoo that houses Moo Deng

sudeng

HIPPO (sudeng) is experiencing increased attention, with community members actively discussing potential pumps and anticipating a comeback. The conversation includes speculation about market influences, recent price drops, and comparisons to other meme coins in the SUI ecosystem, generating both excitement and questions about its future.

Dynavax Technologies Corp. is a biopharmaceutical company, which engages in the provision of discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Emeryville, CA.

Dynavax Technologies Corp.

Dynavax is trending amid discussions about its partnership with Vaxart for an oral COVID-19 vaccine, a potential game-changer in vaccine delivery. The community is weighing the implications of institutional ownership, share buybacks, and a proxy fight involving Deep Track Capital. Some are speculating on potential buyout scenarios and the future direction of Dynavax's strategic partnerships.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is trending amidst lowered sales guidance for 2025, despite a recent revenue beat and expansion of a U.S. Army contract, triggering debate about management's credibility and future prospects. Community discussions revolve around the impact of government delays and the potential for a strong 2026, with some expressing concerns about the company's leadership and others seeing a buying opportunity. The drone sector's overall growth potential remains a key talking point.

Tidal Trust II - YieldMax TSLA Option Income Strategy ETF

YieldMax TSLA Option Income Strategy ETF

TSLY is trending due to news of a potential reverse split, leading to discussions about its impact on the ETF and investor returns. Community members are also weighing in on recent dividend payouts and strategizing around reinvestment and potential trading opportunities. Some are expressing concerns about NAV erosion and comparing TSLY to other high-yield ETFs.

MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.

Mannkind Corp

MannKind (MNKD) is trending due to community discussion around the company's leadership and strategic decisions, particularly regarding CEO Mike Castagna. Debate centers on past agreements, product commercialization, and the potential for a merger or acquisition. Bullish sentiment exists based on analyst upgrades and future growth prospects, while others express concerns about the company's performance and direction.

Dutch Bros, Inc. engages in operating and franchising drive-thru shops that focus on handcrafted beverages. It operates through the Company-Operated Shops, and Franchising and Other segments. The Company-Operated Shops segment consists of coffee shop sales to customers. The Franchising and Other segment is involved in bean and product sales to franchisees and includes the initial franchise fees, royalties, and marketing fees. The company was founded by Travis Boersma and Dane Boersma in 1992 and is headquartered in Tempe, AZ.

Dutch Bros Inc - Ordinary Shares - Class A

Dutch Bros Inc

Dutch Bros is trending amidst discussions about upcoming earnings and its potential growth compared to competitors like Starbucks. Community members are weighing factors such as tariff reductions, expansion strategies, and consumer spending habits, while some debate the stock's valuation and potential price movement. Bullish sentiment is building towards earnings, though concerns about consumer spending and the overall economic climate remain.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Denali Therapeutics (NASDAQ:DNLI) Trading 8.8% Higher - Here's Why

Denali Therapeutics (NASDAQ:DNLI) Shares Up 8.8% - Here's What Happened...

FY2028 Earnings Estimate for DNLI Issued By Leerink Partnrs

Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) - Analysts at Leerink Partnrs reduced their FY2028 earnings per share (EPS) estimates for shares of Denali Therapeutics in a report released on...

FY2029 EPS Estimates for Denali Therapeutics Cut by Wedbush

Denali Therapeutics Inc. (NASDAQ:DNLI - Free Report) - Stock analysts at Wedbush reduced their FY2029 EPS estimates for shares of Denali Therapeutics in a research note issued to investors on Friday...

Denali Therapeutics (NASDAQ:DNLI) Releases Earnings Results

Denali Therapeutics (NASDAQ:DNLI - Get Free Report) announced its earnings results on Thursday. The company reported ($0.74) earnings per share for the quarter, topping the consensus estimate of...

DNLI Posts Narrower-Than-Expected Q3 Loss, Advances MPS IIIA Drug 

Denali's Q3 loss widens year over year as expenses rise, while the FDA delays its review of the firm???s key Hunter syndrome therapy to 2026.

FDA Extends Review of DNLI's Hunter Syndrome Drug by Three Months 

Denali Therapeutics faces an FDA review delay for its Hunter syndrome drug, pushing potential approval of tividenofusp alfa to April 2026.


Why Is Denali Therapeutics (DNLI) Up 16.2% Since Last Earnings Report?

Denali Therapeutics (DNLI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

DNLI Tops on Q2 Earnings, Expects Decree on Hunter Syndrome Drug in '26

Denali Therapeutics posts narrower-than-expected Q2 loss. The company advances multiple rare disease therapies toward potential approvals.

Catalyst Pharmaceutics to Report Q2 Earnings: What's in the Cards?

CPRX gears up to report Q2 results as Firdapse sales rise, Agamree grows, and Fycompa faces a post-patent dip.

Amgen Gears Up to Report Q2 Earnings: Will the Beat Streak Continue?

AMGN eyes another earnings beat as strong drug volumes offset pricing pressure and biosimilar headwinds.

Denali Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates for neurodegenerative diseases. Its product pipeline includes LRRK2, RIPK1, TREM2, and Tau. The company was founded by Ryan J. Watts, Marc Tessier-Lavigne, and Alexander Schuth on October 14, 2013 and is headquartered in San Francisco, CA.

Denali Therapeutics Inc

Will NVIDIA ($NVDA) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

) beat quarterly earnings? 
 
*Powered by Polymarket

DNLI
Denali Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest DNLI News

DNLIDenali Therapeutics Inc